Term
|
Definition
| Generic Name Type of Drug Standard Concentration IV Dose Type of Agent |
|
|
Term
|
Definition
| Sodium Thiopental Barbiturate 25 mg/mL 3-5 mg/kg Induction agent 4 |
|
|
Term
|
Definition
| Propofol Diisopropylphenol 10 mg/mL 1.5-2.5 mg/kg Induction agent 4 |
|
|
Term
|
Definition
| Etomidate Carboxylated imidazole 2 mg/mL 0.1-0.4 mg/kg Induction agent 4 |
|
|
Term
|
Definition
| Ketamine Phencyclidine 5-100 mg/mL 1-2.5 mg/kg Induction agent 4 |
|
|
Term
|
Definition
| Midazolam Benzodiazepine 1-5 mg/mL 0.025-0.06 mg/kg Sedative 2 |
|
|
Term
|
Definition
| Diazepam Benzodiazepine 5-10 mg/mL 0.05-0.2 mg/kg Sedative 2 |
|
|
Term
|
Definition
| Fentanyl Opioid 50 mcg/mL 0.5-2 mcg/kg Narcotic 6 |
|
|
Term
|
Definition
| Morphine Opioid 10 mg/mL 0.05-0.2 mg/kg Narcotic 6 |
|
|
Term
|
Definition
| Sufentanil Opioid 50 mcg/mL 0.05-0.2 mcg/kg Narcotic 6 |
|
|
Term
|
Definition
| Remifentanil Opioid 2 mg/mL 0.25 mcg/kg Narcotic 6 |
|
|
Term
|
Definition
| Meperidine Opioid 25-50 mg/mL 0.5-2 mg/kg Narcotic 6 |
|
|
Term
|
Definition
| Naloxone Opioid Antagonist 0.4 mg/mL 1-4 mcg/kg Narcotic 6 |
|
|
Term
|
Definition
| Ondansetron 5-HT3 antagonist 4 mg/mL 0.15 mg/kg AntiEmetic 4 |
|
|
Term
|
Definition
| Dolasetron 5-HT3 antagonist 12.5 mg/mL 12.5-25 mg AntiEmetic 4 |
|
|
Term
|
Definition
| Inapsine Dopamine antagonist 2.5 mg/mL 15 mcg/kg AntiEmetic 4 |
|
|
Term
|
Definition
| Metoclopramide Cholinomimetic 10 mg/mL 0.15-0.2 mg/kg AntiEmetic 4 |
|
|
Term
|
Definition
| Succinylcholine Depolarizing MR 20 mg/mL 1-2 mg/kg Muscle Relaxant 5 |
|
|
Term
|
Definition
| Rocuronium Non-depolarizing MR 10 mg/mL 0.6-1.2 mg/kg Muscle Relaxant 5 |
|
|
Term
|
Definition
| Vecuronium Non-depolarizing MR 1 mg/mL 0.08-0.12 mg/kg Muscle Relaxant 5 |
|
|
Term
|
Definition
| Pancuronium Non-depolarizing MR 1-2 mg/mL 0.1-0.2 mg/kg Muscle Relaxant 5 |
|
|
Term
|
Definition
| Cisatracurium Non-depolarizing MR 2 mg/mL 0.08-0.12 mg/kg Muscle Relaxant 5 |
|
|
Term
|
Definition
| Edrophonium Cholinesterase inhibitor 10 mg/mL 0.5-1 mg/kg Reversal Agent 4 |
|
|
Term
|
Definition
| Neostigmine Cholinesterase inhibitor 0.5-1 mg/mL 0.04-0.08 mg/kg Reversal Agent 4 |
|
|
Term
|
Definition
| Atropine Cholinergic antagonist 0.1-0.4 mg/mL 0.01-0.03 mg/kg Reversal Agent 4 |
|
|
Term
|
Definition
| Glycopyrrolate Cholinergic antagonist 0.2 mg/mL 0.01-0.02 mg/kg Reversal Agent 4 |
|
|
Term
|
Definition
| Phenylephrine Adrenergic agonist 10 mg/mL 0.5-1.5 mcg/kg Andrenergic Agent 7 |
|
|
Term
|
Definition
| Epinephrine Adrenergic agonist 1 mg/mL 2-10 mcg/kg Andrenergic Agent 7 |
|
|
Term
|
Definition
| Ephedrine Adrenergic agonist 50 mg/mL 0.1-0.2 mg/kg Andrenergic Agent 7 |
|
|
Term
|
Definition
| Norepinephrine Adrenergic agonist 1 mg/mL 4-16 mcg Andrenergic Agent 7 |
|
|
Term
|
Definition
| Labetalol Adrenergic antagonist 5 mg/mL 0.1-0.5 mg/kg Andrenergic Agent 7 |
|
|
Term
|
Definition
| Esmolol Beta antagonist 10 mg/mL 0.2-0.5 mg/kg Andrenergic Agent 7 |
|
|
Term
|
Definition
| Metoprolol Beta antagonist 1 mg/mL 0.05-0.1 mg/kg Andrenergic Agent 7 |
|
|
Term
|
Definition
| Lidocaine Amide LA 20 mg/mL 0.5-1 mg/kg Local Anesthesic 1 |
|
|
